Basic research or specialised advanced schools: the allotted budget to consolidate the position of excellence of Swiss universities is considerable. Thus, Switzerland spends 880.20 US$ per inhabitant in research and development, or 2.57% of its GDP, ranking second after the United States. This long-term policy maintains innovation and enables enterprises active in life sciences or high-tech technologies to remain competitive.
Three priority directives of economic development containing numerous possibilities of collaboration between the institutes and enterprises have been defined for the region. They are about :
- Life sciences. This sector has three university hospitals (CHUV, HUG, Inselspital) and three major research institutes (ISREC, Institut Ludwig and SIB). An important part of the actors (universities and industries) in this sector are grouped together under the BioAlps label.
- Information and communication technologies with the presence of CERN in Geneva.
- Micro- and nanotechnologies, with, notably, the presence of the Swiss Centre of Electronics and Micro-technology (CSEM), as well as the Institute of Micro-technology (IMT), as well as the Swiss Foundation for Research in Micro-technology (FSRM) in Neuchâtel.
For the many programmes conducted in these different institutions, the collaboration is international, be it for fundamental or applied research. This situation allows even very small enterprises that are active in Western Switzerland to have access to the latest developments that their ambitions require.
Journée de l'Innovation 2017 aux HUG Jeudi 19 octobre19.10.201711ème Journée de l’innovation au Centre de l’innovation des HUG. Conférences, concours de pitchs, remise des...
Pryv SA closes 1.1M CHF Pre-Series A to accelerate growth and prepare Series A funding roundPryv SA, an independent Swiss Health-IT company, specialized in providing innovative data management and digital...
Pharmasys CH - SuisseProfessional Services & Consulting, IT Services / Information Provider
Pharmasys founded in 2005 is a growing consultant company for healthcare industry with office in France, Belgium and Switzerland.
Professional Services & Consulting, Quality
Our goal is to provide customized consulting services in Engineering, Quality, Data Integrity and GxP Compliance of automated and computerized systems in the regulated health care sector: pharmaceutical, cosmetics, medical devices.
Our interventions rely on years of experience methods based rigorously on ISPE guidelines (e.g. GAMP 5). Those methods allow us to respond pragmatically to any regulatory compliance: FDA, 21 CFR Part 11, EU Chapter 4 Annex 11, cGMP's, GMP, GLP, GDP, GCP, 21 CFR Part 820, CE Mark, ISO 13485, ISO 14971, IEC 62304
Pharmasys Group provides expertise in the implementation of demanding projects and the validation of complex system as well as training staff with the latest market standards.